There’s certainly plenty of demand for and hype around the new wave of weight loss agents. But insurers are pulling back on coverage of these products.
There’s certainly plenty of demand for and hype around the new wave of weight loss agents. But insurers are pulling back on coverage of these products.
Not quite 18 months after being named CEO of Truepill, cofounder Sid Viswanathan is gone. The company, worth $1.6 billion at its last equity funding round, faces an uncertain future with a cash squeeze and DEA investigation.
Alignment Healthcare Thursday reported a loss in its second quarter of $28.5 million even as the startup provider of Medicare Advantage coverage grows its membership.
A Montana based molecular diagnostic company, Alercell Inc., is pioneering novel techniques to augment the way leukemia is diagnosed, treated and ultimately prevented.